Edition:
United Kingdom

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

120.00EUR
10:46am BST
Change (% chg)

€0.20 (+0.17%)
Prev Close
€119.80
Open
€120.20
Day's High
€121.20
Day's Low
€119.40
Volume
2,468
Avg. Vol
10,685
52-wk High
€154.20
52-wk Low
€102.10

Chart for

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €1,048.79
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 29.47 30.95 32.75
EPS (TTM): 4.21 -- --
ROI: 3.67 14.84 14.38
ROE: 7.75 16.34 16.07

BRIEF-Virbac Q1 Revenue Up At 193.5 Million Euros

* VIRBAC : 2018 FIRST QUARTER REVENUE ROSE BY +3.3% AT COMPARABLE EXCHANGE RATES

12 Apr 2018

Animal medicines group Virbac sees slow sales growth this year

March 14 French veterinary pharmaceutical company Virbac expects a low-single-digit increase in revenue at constant exchange rates this year partly due to weakness in the U.S. market, it said on Wednesday.

14 Mar 2018

BRIEF-Virbac FY Net Profit From Ordinary Activities Down 16.3 Pct At 29.5 Million Euros

* VIRBAC: OPERATING PROFIT FROM ORDINARY ACTIVITIES 2017 COMPARABLE TO 2016

14 Mar 2018

BRIEF-Virbac Q4 Sales Up At 231.5 Million Euros

* ANNUAL SALES COMPARABLE TO 2016 AT CONSTANT EXCHANGE RATES AFTER STRONG FOURTH-QUARTER GROWTH

16 Jan 2018

Earnings vs. Estimates